National Health Accounts

 

Announcements - 2004

UNDP/World Bank/WHO Special Programme for research and Training in Tropical Diseases (TDR) Announces Collaborative Research Grants, 26 February 2004

 

I. RATIONALE AND BACKGROUND

The UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) invites applications for the award of Collaborative Research Grants (CRGs) to research institutions and scientists from least developed endemic countries (LDCs), and from high-burden countries for TDR target diseases on the following two research areas defined by the Steering Committee on Social, Economic, and Behavioral Research (SEB):

*      Determinants of inequality of access to prevention, therapy and information; and

*      Implications of changing economic, social, political and civil structures (including health reforms) for disease persistence, emergence, resurgence and factors affecting them such as drug and insecticide resistance.

Please consult the TDR WebPages for social research:

http://www.who.int/tdr/topics/social-research/default.htm for focus research areas and the current work plan.

As outlined in basic documents on the website, SEB aims to promote and support research that critically examines social, economic and behavioural issues related to disease persistence and emergence and contributes to innovative thinking about improved control and prevention of TDR diseases. Despite significant, global efforts over the last 50 years, communicable diseases continue to obstruct social and economic development in developing countries, and disproportionately affect the poorest and most marginali zed populations. A better understanding of how social, behavioural, political, economic and health system factors operate to affect disease patterns and disease control efforts will be important for identifying future needs, opportunities and innovations for improved control of TDR diseases (African trypanosomiasis, Chagas disease, dengue fever, leishmaniasis, leprosy, lymphatic filariasis, malaria, onchocerciasis, schistosomiasis, and tuberculosis).

Collaborative Research Grants are the main type of research grant awarded by TDR. They are intended to support goal-oriented research.

 

II. SPECIFIC OBJECTIVES

Through this call, SEB requests research proposals on the following:

A. Inequality of access to prevention, therapy and information

What factors affect access of populations to prevention, existing therapies, and information regarding TDR diseases? Factors that could be examined include those at the household/community, health systems and services, and non-health sectors/central government levels and may examine a wide range of inequalities (i.e., social, socio-economic, political, geographic, gender- or ethnicity-related inequalities). SEB is particularly interested in studies that consider two or more levels of analysis and the links between them. Examples could include "Identifying and differentially weighting the factors promoting the emergence of drug-resistant malaria in ..." or investigating "Social inequalities and the emergence of drug-resistant tuberculosis in ...:  linking molecular epidemiology with social analysis".

Research questions of particular interest include but need not be confined to:

*      How can governments extend access and improve equity through provision, financing and regulation? An example may entail 'An economic and social science analysis of provision for disease control programs in contracts between the Central Board of Health and District Health Management teams in country x'.

*      What are the implications of different kinds of public/private partnerships for equity in access to pharmaceuticals and services.

*      What can be learned from existing or past partnerships, and how might we best assess their impact on equity? To what extent are the needs of vulnerable populations being met through such partnerships? Partners might include the public sector, private-for-profit firms, donors, NGOs etc.

*      How can different approaches for increasing access to proven therapies, prevention and information be best utilized to contribute to improved disease control? (An example may be investigating "Changes in access to information about treatment and prevention of malaria in urban and rural (name of country)". seen in the context of exposure to new communication channels and media and general socio-cultural factors.

B. Implications of changing economic, social, political and civil structures for infectious disease persistence, emergence and resurgence; and for drug and pesticide resistance

Globalization may have potential for certain people and population groups, however, for poor marginalized populations, in both the non-formal as well as formal economic sectors of developing countries, globalization can bring along more inequality, more marginalization and more poverty. Globalization brings about the need to develop new approaches to public health. Specifically, for the ten TDR disease, we don't exactly know how processes of globalization affect disease control efforts and/or the epidemiology of infectious disease. Research questions of particular interest include but need not be confined to:

*      What is the impact (positive and negative) of large-scale economic processes and policies on the production and availability of effective drugs, diagnostics and vaccines? Examples of some large scale processes that might be examined are questions of intellectual property rights, trade agreements, decentralization and/or privatization of services.

*      What are the global forces and conditions promoting or retarding the development and equitable distribution of effective preventive, diagnostic, and/or therapeutic technologies?

*      What are the social, economic and political determinants of drug use patterns (at household, community, health systems and central government levels), and what are the implications of these, e.g., for drug resistance.

*      How are household choices and actions constrained or enabled by local and large scale forces and processes?

 

III. HOW THE STEERING COMMITTEE WORKS

The SEB Steering Committee holds one meeting per year (in May) during which it updates its work plan, reviews new research proposals and monitors overall progress of the Committee. The Committee invites individual research projects with budgets normally not to exceed $35,000 per year for a period of one to two years. The committee is particularly interested in supporting projects that involve South-South and South-North partnerships between institutions and individuals that will contribute to research capacity building for social science research in disease endemic countries. For group projects and, in exceptional cases individual projects, the Committee will consider projects requiring greater levels of funding.

 

IV. HOW TO APPLY

Detailed Proposal Development Guidelines for SEB research are available on the TDR website at:

http://www.who.int/tdr/topics/social-research/guidelines.htm and should be closely followed while developing the proposal. Collaborative Research Grant (CRG) application forms and instructions are available from TDR at http://www.who.int/tdr/grants/grants/collgrant.htm.

Please note the committee's ground rules for proposal submission:

A. DEVELOPING THE PROPOSAL

1.         The proposal should include a title that clearly covers the entire study.

2.         Within the prescribed length of four to six pages (TDR form page 7 plus additional three to five pages), the proposal must have:

a.      A problem statement and a short and concise background of the research problem, including a description of the relevance to the call for applications and the research problem's significance to TDR diseases.

b.      A short literature review pertaining to the research problem.

c.      An analytic conceptual framework

d.      Clearly stated general and specific research objectives. The proposal should show congruence between objectives and methods, and between general and specific objectives.

e.      Theoretical and operational definitions of terms

f.       A clearly described methodology, including research design, sampling design and sample size, research techniques, research instrument indicators, and plans for data management and analysis.

g.      An explicit statement regarding ethical concerns with strategies how to address them.

h.      A realistic time plan

i.        A description of the roles of each designated investigator

j.       A dissemination plan, including if and how policy makers and other stakeholders might be involved

k.      A budget according TDR's rules for admissible items for support

 

B. SUBMITTING THE PROPOSAL

3.      The proposal must be submitted on time

4.      The proposal must be submitted on TDR forms

5.      The proposal must be submitted with original signatures of  institutional representatives and PIs. Proposals submitted only via e-mail will not be reviewed at the meeting of the steering committee

6.      Incomplete proposals and proposals submitted after the closing date will not be reviewed

7.      The proposal must be submitted with research instruments and consent forms

8.      The proposal must be submitted with national government clearance (where needed) and ethical clearance from a national ethical review board. Proposals without these clearances cannot be reviewed.

 

C. THE RESEARCH TEAM

9.      Each research team must include a trained social scientist experienced in multi-disciplinary work as called upon and needed by the call for grant applications. Applicants should also consider bringing together senior and junior social scientists

10.   The team's expertise must meet the research objective(s) and preferably be multi-disciplinary

11.   The principal investigator (PI) should ideally be a national of a so-called Disease-Endemic Country (DEC), i.e. a country where the disease(s) under study is (are) endemic or occurring epidemically and should reside in a DEC. An exception will be made for a PI-DEC national residing in a non-DEC, e.g., "Northern country who can submit a proposal as PI, however, only with strong involvement of DEC investigators residing in the DC and with the DC institution as contractual "home" institution for funding. Clarification of collaboration should be provided. "Northern" collaborators may not act as co-investigators but may be included as external scientists - on the research team.

 

Applications can be submitted in English and French only. The steering committee encourages research teams from other major language areas (e.g., Spanish, Lusophone, or Arabic-speaking countries) to apply in English or French.

If you are interested in submitting a proposal to the SEB Steering Committee an early letter of intent can be submitted to the SEB secretariat to request feedback before developing a full proposal.

Applications will be reviewed by the Steering Committee in May 2004.

 

DEADLINE FOR RECEIPT OF APPLICATIONS AT TDR: Thursday, 26 February 2004.

 

For further details, please contact:

Dr Johannes Sommerfeld

Manager

Steering Committee on Strategic Social, Economic and Behavioral Research (SEB)

TDR,

World Health Organization

1211 Geneva 27,

Switzerland

Tel: (41-22) 791-3954

Fax: (41-22) 791-4854

E-mail: mailto:sommerfeldj@who.int

 

 

 

 

 

 

 

| | | | | |